Why Peptides and Stem Cells Fail When You Skip the Basics
1 month ago
- Sourcing is the whole game: Crozier explains why he refuses corn-based glutathione, screens peptides for mycotoxins, and counts live stem cells instead of debris. In his clinical experience, where a product comes from often decides whether it helps at all.
- Prep the terrain before the therapy: Peptides break their weak bonds and stem cells stall when the cell is depleted, so he restores amino acids, clears heavy metals, and supports the membrane with phosphatidylcholine before layering anything advanced on top.
- Match the tool to the problem, then sequence it: From foundational peptides (epithalon, BPC-157, thymus peptides, GHK-Cu, KPV) to when stem cells versus exosomes make sense, Crozier walks through his order of operations, including giving senolytics before exosomes. Outcomes vary, and he is candid about what the research still can’t confirm.
Comments